| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4161090
Max Phase: Preclinical
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.52
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(O)CC1CC2CCC(C1)N(Cc1ccc3c(c1)Nc1nccnc1S3)C2
Standard InChI: InChI=1S/C21H24N4O2S/c26-19(27)10-15-7-13-1-3-16(8-15)25(11-13)12-14-2-4-18-17(9-14)24-20-21(28-18)23-6-5-22-20/h2,4-6,9,13,15-16H,1,3,7-8,10-12H2,(H,22,24)(H,26,27)
Standard InChI Key: VDCAGIOXIQGNHA-UHFFFAOYSA-N
Associated Targets(Human)
Intercellular adhesion molecule-1 260 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 396.52 | Molecular Weight (Monoisotopic): 396.1620 | AlogP: 4.15 | #Rotatable Bonds: 4 |
| Polar Surface Area: 78.35 | Molecular Species: ZWITTERION | HBA: 6 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 4.12 | CX Basic pKa: 8.97 | CX LogP: 0.69 | CX LogD: 0.69 |
| Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.69 | Np Likeness Score: -0.38 |
References
| 1. Pluta K, Jeleń M, Morak-Młodawska B, Zimecki M, Artym J, Kocięba M, Zaczyńska E.. (2017) Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties., 138 [PMID:28734245] [10.1016/j.ejmech.2017.07.009] |
Source
Source(1):